Question

Difficulty: HardGynecologic Oncology

Match each patient's clinical presentation and associated gynecologic neoplasm with the most likely underlying genetic mutation and hereditary syndrome.

  • A 45-year-old woman with endometrioid endometrial adenocarcinoma; her family history is notable for a brother with colon cancer at age 42 and an aunt with urothelial cancer.Defect in DNA mismatch repair genes (e.g., MLH1, MSH2) leading to microsatellite instability.
  • A 52-year-old woman with ascites and a pelvic mass, diagnosed with high-grade serous carcinoma of the fallopian tube. Her maternal grandmother died of breast cancer.Defect in homologous recombination repair genes (e.g., BRCA1, BRCA2).
  • A 35-year-old woman with a history of macrocephaly and multiple trichilemmomas, who is now diagnosed with early-onset endometrial carcinoma.Defect in a tumor suppressor gene on chromosome 10 (PTEN) regulating the PI3K/AKT/mTOR pathway.
  • A 22-year-old woman with dark blue macules on her buccal mucosa and lips, presenting with a sex cord tumor with annular tubules (SCTAT) of the ovary.Defect in a serine/threonine kinase gene on chromosome 19 (STK11/LKB1).

Answer

The correct matches align Lynch syndrome with mismatch repair defects, Hereditary Breast and Ovarian Cancer (HBOC) with homologous recombination defects, Cowden syndrome with PTEN mutations, and Peutz-Jeghers syndrome with STK11 mutations, based on their classic syndromic presentations.
Each patient presentation provides classic phenotypic and familial clues that define a specific hereditary cancer syndrome with high risk for gynecologic malignancies. Recognizing these unique patterns allows for the precise matching of the clinical syndrome to its underlying genetic defect.

Step-by-Step Solution

1
Analyze the clinical phenotype and family history in each vignette to identify the specific hereditary cancer syndrome.
Identified Lynch syndrome, HBOC, Cowden syndrome, and Peutz-Jeghers syndrome.
Hereditary syndromes often present with distinctive non-gynecologic features (e.g., mucocutaneous lesions) or specific patterns of familial malignancies.
2
Recall the underlying genetic mutation and pathogenesis for each identified syndrome.
Lynch maps to MMR genes, HBOC to BRCA1/2, Cowden to PTEN, and Peutz-Jeghers to STK11.
Understanding the molecular basis of these syndromes is critical for genetic counseling, targeted therapies (e.g., PARP inhibitors for BRCA), and prophylactic surgeries.
3
Match each presentation to the correct corresponding genetic mechanism.
Successfully paired the left and right items based on established genotype-phenotype correlations.
Completes the diagnostic assessment linking clinical presentation to molecular pathology.

Key Concept

Hereditary cancer syndromes and their associated genetic mutations in gynecologic oncology.
Rate this question